FDA approves onabotulinumtoxinA to prevent chronic migraine

News
Article

FDA has approved onabotulinumtoxinA (Botox, Allergan Inc.) injection to prevent headaches in adult patients with chronic migraine.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.